Ceva animal health manufactures and supplies pharmaceutical products and vaccines for companion animals, livestock, swine, and poultry. They focus on creating products to fight avian flu, brucellosis and Q-fever. They are a globalised company with operations in 42 countries and working across 110 countries and more than 3500 employees. Their products are divided into 5 categories companion animals, poultry, cattle, sheep and goats and swine. The company has strategic partnerships with French National Institute of Agricultural Research (INRA) and Nantes Veterinary School. The company was founded in 1977 and is headquartered in Lenexa, Kansas.